Literature DB >> 26833969

Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study.

Paolo Preziosa1,2, Maria A Rocca1,2, Elisabetta Pagani1, Maria Laura Stromillo3, Christian Enzinger4, Antonio Gallo5,6, Hanneke E Hulst7, Matteo Atzori8, Deborah Pareto9, Gianna C Riccitelli1, Massimiliano Copetti1, Nicola De Stefano3, Franz Fazekas4, Alvino Bisecco5,6, Frederik Barkhof7, Tarek A Yousry8, Maria J Arévalo9, Massimo Filippi1,2.   

Abstract

In a multicenter setting, we applied voxel-based methods to different structural MR imaging modalities to define the relative contributions of focal lesions, normal-appearing white matter (NAWM), and gray matter (GM) damage and their regional distribution to cognitive deficits as well as impairment of specific cognitive domains in multiple sclerosis (MS) patients. Approval of the institutional review boards was obtained, together with written informed consent from all participants. Standardized neuropsychological assessment and conventional, diffusion tensor and volumetric brain MRI sequences were collected from 61 relapsing-remitting MS patients and 61 healthy controls (HC) from seven centers. Patients with ≥2 abnormal tests were considered cognitively impaired (CI). The distribution of focal lesions, GM and WM atrophy, and microstructural WM damage were assessed using voxel-wise approaches. A random forest analysis identified the best imaging predictors of global cognitive impairment and deficits of specific cognitive domains. Twenty-three (38%) MS patients were CI. Compared with cognitively preserved (CP), CI MS patients had GM atrophy of the left thalamus, right hippocampus and parietal regions. They also showed atrophy of several WM tracts, mainly located in posterior brain regions and widespread WM diffusivity abnormalities. WM diffusivity abnormalities in cognitive-relevant WM tracts followed by atrophy of cognitive-relevant GM regions explained global cognitive impairment. Variable patterns of NAWM and GM damage were associated with deficits in selected cognitive domains. Structural, multiparametric, voxel-wise MRI approaches are feasible in a multicenter setting. The combination of different imaging modalities is needed to assess and monitor cognitive impairment in MS.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  atrophy; cognitive impairment; diffusion tensor MRI; multicenter; multiple sclerosis; voxel-wise analysis

Mesh:

Year:  2016        PMID: 26833969      PMCID: PMC6867484          DOI: 10.1002/hbm.23125

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  32 in total

1.  Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain.

Authors:  N Tzourio-Mazoyer; B Landeau; D Papathanassiou; F Crivello; O Etard; N Delcroix; B Mazoyer; M Joliot
Journal:  Neuroimage       Date:  2002-01       Impact factor: 6.556

2.  Reduction of eddy-current-induced distortion in diffusion MRI using a twice-refocused spin echo.

Authors:  T G Reese; O Heid; R M Weisskoff; V J Wedeen
Journal:  Magn Reson Med       Date:  2003-01       Impact factor: 4.668

Review 3.  Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis.

Authors:  Maria A Rocca; Maria P Amato; Nicola De Stefano; Christian Enzinger; Jeroen J Geurts; Iris-K Penner; Alex Rovira; James F Sumowski; Paola Valsasina; Massimo Filippi
Journal:  Lancet Neurol       Date:  2015-02-04       Impact factor: 44.182

4.  Accumulation of cortical lesions in MS: relation with cognitive impairment.

Authors:  S D Roosendaal; B Moraal; P J W Pouwels; H Vrenken; J A Castelijns; F Barkhof; J J G Geurts
Journal:  Mult Scler       Date:  2009-05-12       Impact factor: 6.312

5.  Wallerian and trans-synaptic degeneration contribute to optic radiation damage in multiple sclerosis: a diffusion tensor MRI study.

Authors:  Maria A Rocca; Sarlota Mesaros; Paolo Preziosa; Elisabetta Pagani; Tatjana Stosic-Opincal; Irena Dujmovic-Basuroski; Jelena Drulovic; Massimo Filippi
Journal:  Mult Scler       Date:  2013-04-09       Impact factor: 6.312

6.  Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes.

Authors:  Declan T Chard; Jonathan S Jackson; David H Miller; Claudia A M Wheeler-Kingshott
Journal:  J Magn Reson Imaging       Date:  2010-07       Impact factor: 4.813

7.  The brief repeatable battery of neuropsychological tests: normative values allow application in multiple sclerosis clinical practice.

Authors:  J B Boringa; R H Lazeron; I E Reuling; H J Adèr; L Pfennings; J Lindeboom; L M de Sonneville; N F Kalkers; C H Polman
Journal:  Mult Scler       Date:  2001-08       Impact factor: 6.312

8.  Connecting white matter injury and thalamic atrophy in clinically isolated syndromes.

Authors:  Roland G Henry; Mason Shieh; Bagrat Amirbekian; SungWon Chung; Darin T Okuda; Daniel Pelletier
Journal:  J Neurol Sci       Date:  2009-04-23       Impact factor: 3.181

9.  Relevance of brain lesion location to cognition in relapsing multiple sclerosis.

Authors:  Francesca Rossi; Antonio Giorgio; Marco Battaglini; Maria Laura Stromillo; Emilio Portaccio; Benedetta Goretti; Antonio Federico; Bahia Hakiki; Maria Pia Amato; Nicola De Stefano
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

10.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

View more
  26 in total

1.  Altered hippocampal GABA and glutamate levels and uncoupling from functional connectivity in multiple sclerosis.

Authors:  Fei Gao; Xuntao Yin; Richard A E Edden; Alan C Evans; Junhai Xu; Guanmei Cao; Honghao Li; Muwei Li; Bin Zhao; Jian Wang; Guangbin Wang
Journal:  Hippocampus       Date:  2018-11       Impact factor: 3.899

Review 2.  Future Brain and Spinal Cord Volumetric Imaging in the Clinic for Monitoring Treatment Response in MS.

Authors:  Tim Sinnecker; Cristina Granziera; Jens Wuerfel; Regina Schlaeger
Journal:  Curr Treat Options Neurol       Date:  2018-04-20       Impact factor: 3.598

3.  Cognitive performance in multiple sclerosis: the contribution of intellectual enrichment and brain MRI measures.

Authors:  Gabriella Santangelo; Alvino Bisecco; Luigi Trojano; Rosaria Sacco; Mattia Siciliano; Alessandro d'Ambrosio; Marida Della Corte; Luigi Lavorgna; Simona Bonavita; Gioacchino Tedeschi; Antonio Gallo
Journal:  J Neurol       Date:  2018-05-26       Impact factor: 4.849

Review 4.  Aging of cerebral white matter.

Authors:  Huan Liu; Yuanyuan Yang; Yuguo Xia; Wen Zhu; Rehana K Leak; Zhishuo Wei; Jianyi Wang; Xiaoming Hu
Journal:  Ageing Res Rev       Date:  2016-11-16       Impact factor: 10.895

5.  NODDI, diffusion tensor microstructural abnormalities and atrophy of brain white matter and gray matter contribute to cognitive impairment in multiple sclerosis.

Authors:  Paolo Preziosa; Elisabetta Pagani; Alessandro Meani; Olga Marchesi; Lorenzo Conti; Andrea Falini; Maria A Rocca; Massimo Filippi
Journal:  J Neurol       Date:  2022-10-06       Impact factor: 6.682

6.  Hippocampal and Deep Gray Matter Nuclei Atrophy Is Relevant for Explaining Cognitive Impairment in MS: A Multicenter Study.

Authors:  D Damjanovic; P Valsasina; M A Rocca; M L Stromillo; A Gallo; C Enzinger; H E Hulst; A Rovira; N Muhlert; N De Stefano; A Bisecco; F Fazekas; M J Arévalo; T A Yousry; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2016-09-29       Impact factor: 3.825

7.  Volume loss in the deep gray matter and thalamic subnuclei: a longitudinal study on disability progression in multiple sclerosis.

Authors:  Stefano Magon; Charidimos Tsagkas; Laura Gaetano; Raihaan Patel; Yvonne Naegelin; Michael Amann; Katrin Parmar; Athina Papadopoulou; Jens Wuerfel; Christoph Stippich; Ludwig Kappos; M Mallar Chakravarty; Till Sprenger
Journal:  J Neurol       Date:  2020-02-10       Impact factor: 4.849

8.  Hippocampal Neurogenesis and Neural Circuit Formation in a Cuprizone-Induced Multiple Sclerosis Mouse Model.

Authors:  Hai Zhang; Yeonghwan Kim; Eun Jeoung Ro; Cindy Ho; Daehoon Lee; Bruce D Trapp; Hoonkyo Suh
Journal:  J Neurosci       Date:  2019-11-12       Impact factor: 6.167

Review 9.  Gray Matter Atrophy in the Cortico-Striatal-Thalamic Network and Sensorimotor Network in Relapsing-Remitting and Primary Progressive Multiple Sclerosis.

Authors:  Yuan Cao; Wei Diao; Fangfang Tian; Feifei Zhang; Laichang He; Xipeng Long; Fuqinq Zhou; Zhiyun Jia
Journal:  Neuropsychol Rev       Date:  2021-02-13       Impact factor: 7.444

10.  Immunomodulation Eliminates Inflammation in the Hippocampus in Experimental Autoimmune Encephalomyelitis, but Does Not Ameliorate Anxiety-Like Behavior.

Authors:  Pece Kocovski; Nuzhat Tabassum-Sheikh; Stephanie Marinis; Phuc T Dang; Matthew W Hale; Jacqueline M Orian
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.